Treatment-Related Predictive and Prognostic Factors in Trimodality Approach in Stage IIIA/N2 Non-Small Cell Lung Cancer.

Jeremic, Branislav; Casas, Francesc; Dubinsky, Pavol; Gomez-Caamano, Antonio; Cihoric, Nikola; Videtic, Gregory; Igrutinovic, Ivan

Jeremic, Branislav; Casas, Francesc; Dubinsky, Pavol; Gomez-Caamano, Antonio; Cihoric, Nikola; Videtic, Gregory; Igrutinovic, Ivan.

Afiliação

Jeremic B; BioIRC R&D Centre for Biomedical Research, Kragujevac, Serbia.
Casas F; University Clinic, Barcelona, Spain.
Dubinsky P; University Hospital to East Slovakia Institute of Oncology, Kosice, Slovakia.
Gomez-Caamano A; University Hospital, Santiago de Compostela, Spain.
Cihoric N; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Videtic G; Cleveland Clinic, Cleveland, OH, United States.
Igrutinovic I; Faculty of Science, University of Kragujevac, Kragujevac, Serbia.

Front Oncol ; 8: 30, 2018.

Article em En | MEDLINE | ID: mdl-29527511

Palavras-chave

non-small cell lung cancer; predictive factors; prognostic factors; stage IIIA/pN2; trimodality therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google